image: After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States. Substantial support for breast cancer awareness and research funding has helped create advances in the diagnosis and treatment of breast cancer. view more
Credit: WWW.ONCOTARGET.COM
BUFFALO, NY-November 18, 2020 – Each year, an estimated 40,000+ women and men lose the battle against breast cancer in the United States. After skin cancer, breast cancer is the most commonly diagnosed cancer in women.
Oncotarget launched the new Special Collections series on the free-to-read and rigorously peer-reviewed journal's website. The first collection in this series is the Special Collection on breast cancer—which includes numerous recently published scientific papers that pertain to breast cancer research in the Oncotarget Journal.
“Special Collections are useful tools for researchers who are interested in learning from previously published studies about a specific topic,” the Oncotarget Media Office explains.
Papers included in this collection relate to new prognostic markers, risk factors, therapies, gene and protein studies, oncogenes, and other target mechanisms that may be used to treat breast cancer. This free-to-read collection is designed to be an open access resource for the medical science community to promote a better understanding of all the latest and most important breast cancer research.
“This new collection can be used as a resource to help researchers and scientists design new studies that may lead to novel breakthroughs in breast cancer treatments and therapies,” the Oncotarget Media Office said.
###
Read the new Oncotarget Special Collection on breast cancer.
Read a blog about this new resource.
About Oncotarget by Impact Journals:
Oncotarget is a primarily oncology-focused, world-class, peer-reviewed, open access, and weekly journal that is published every Tuesday. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases.
For media requests, please contact: media@impactjournals.com
Oncotarget | Impact Journals
Impact Journals LLC
6666 E.Quaker St. Ste. 1
Orchard Park, NY 14127
Journal
Oncotarget